Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T4528 |
Tyrphostin AG 528
Tyrphostin B66,AG 528 |
EGFR | Angiogenesis; JAK/STAT signaling; Tyrosine Kinase/Adaptors |
Tyrphostin AG 528 (Tyrphostin B66) 是一种蛋白酪氨酸激酶抑制剂,对表皮生长因子受体 (EGFR) 的IC50为 4.9 μM,对ErbB2的IC50为 2.1 μM,具有抗癌作用。 | |||
T7649 |
Tyrphostin A1
AG9,(4-甲氧基苄烯)丙二腈,Tyrphostin 1 |
EGFR; Interleukin | Angiogenesis; Immunology/Inflammation; JAK/STAT signaling; Tyrosine Kinase/Adaptors |
Tyrphostin A1 (Tyrphostin 1) 对巨噬细胞培养中CD40L 刺激的IL-12产生和抗原诱导的Th1细胞生成具有抑制作用。 | |||
T2063 |
Tyrphostin 23
RG-50810,TX 825,Tyrphostin A23,AG18 |
EGFR | Angiogenesis; JAK/STAT signaling; Tyrosine Kinase/Adaptors |
Tyrphostin 23 (AG18) 是一种EGFR 抑制剂,IC50值为35 μM。 | |||
T2479 |
Tyrphostin A9
Malonoben,Tyrphostin 9,SF 6847,AG 17,RG-50872 |
EGFR; VEGFR; Influenza Virus; PDGFR | Angiogenesis; JAK/STAT signaling; Microbiology/Virology; Tyrosine Kinase/Adaptors |
Tyrphostin A9 (SF 6847) 是一种线粒体分裂诱导剂,是 PDGFR 抑制剂,具有抗流感病毒的活性。 | |||
T6711 |
Tyrphostin AG1296
Tyrphostin AG 1296,AG 1296 |
Apoptosis; FGFR; FLT; PDGFR; c-Kit | Angiogenesis; Apoptosis; Tyrosine Kinase/Adaptors |
Tyrphostin AG1296 (Tyrphostin AG 1296) 抑制人PDGF α和β受体以及相关干细胞因子受体的信号传导,是一种选择性血小板衍生生长因子受体抑制剂,IC50值为 0.8 μM。 | |||
T21622 |
Tyrphostin A25
AG-82,Tyrphostin AG 82,RG-50875 |
EGFR; GPR | Angiogenesis; Endocrinology/Hormones; GPCR/G Protein; JAK/STAT signaling; Tyrosine Kinase/Adaptors |
Tyrphostin A25 (Tyrphostin AG 82)是一种特异性的EGFR 酪氨酸激酶抑制剂和GPR35激动剂,对GPR35的IC50值为 0.94 μM,对GPR35的EC50值为 5.3 μM。 | |||
T13238 |
Tyrphostin AG1433
SU1433,AG1433 |
VEGFR; PDGFR | Angiogenesis; Tyrosine Kinase/Adaptors |
Tyrphostin AG1433 (AG1433) 是选择性的PDGFRβ和VEGFR-2 (Flk-1/KDR)抑制剂,IC50分别为 5.0 μM 和 9.3 μM。Tyrphostin AG1433有防止血管形成的活性。 | |||
T7101 |
Tyrphostin AG30
Tyrphostin AG30(AG30),酪氨酸磷酸化抑制剂 AG 30 |
EGFR; Tyrosine Kinases | Angiogenesis; JAK/STAT signaling; Tyrosine Kinase/Adaptors |
Tyrphostin AG30 (AG30) 是一种有效的蛋白质酪氨酸激酶 (PTK) 抑制剂,选择性地抑制 c-ErbB 的自我更新诱导,并能抑制原发性红细胞 c-ErbB 激活 STAT5。 | |||
T34973 |
Tyrphostin 8
4-Hydroxybenzylidenemalononitrile |
EGFR; GTPase | Angiogenesis; GPCR/G Protein; JAK/STAT signaling; Tyrosine Kinase/Adaptors |
Tyrphostin 8(4-Hydroxybenzylidenemalononitrile) 是一种有效的 GTP 酶抑制剂,对 EGFR 激酶有抑制作用, IC50 值为 560 μM。Tyrphostin 8 可抑制蛋白丝氨酸/苏氨酸钙调磷酸酶 (IC50=21 μM),增强 Caco-2 细胞中转铁蛋白受体介导的转吞作用,并增加口服胰岛素 - 转铁蛋白的降血糖作用。 | |||
T8534 |
Tyrphostin AG 112
|
EGFR | Angiogenesis; JAK/STAT signaling; Tyrosine Kinase/Adaptors |
Tyrphostin AG 112 是一种EGFR 磷酸化抑制剂。 | |||
T6712 |
Tyrphostin AG 879
AG 879 |
Apoptosis; EGFR; Trk receptor; HER; PDGFR | Angiogenesis; Apoptosis; JAK/STAT signaling; Tyrosine Kinase/Adaptors |
Tyrphostin AG 879 (AG 879) 是一种抑制TrKA 磷酸化的酪氨酸激酶抑制剂,IC50为 10 μM。它还是一种选择性ErbB2酪氨酸激酶抑制剂,IC50为 1 μM,具有抗癌活性。 | |||
T22450 |
Tyrphostin B44, (+) enantiomer
酪氨酸磷酸化抑制剂AG 835 |
EGFR | Angiogenesis; JAK/STAT signaling; Tyrosine Kinase/Adaptors |
Tyrphostin B44, (+) enantiomer 是一种表皮生长因子受体 (EGFR) 激酶抑制剂,IC50 为 0.86 μM,活性低于 (-) 对映体。 | |||
T67707 |
Tyrphostin AG 538
AG 538 |
IGF-1R | Tyrosine Kinase/Adaptors |
Tyrphostin AG 538 是一种查尔酮化合物,是一种IGF-1受体激酶抑制剂(IC₅0 :为400 nM),具有有效性、细胞渗透性、可逆性和竞争性。 | |||
T11593 |
I-OMe-Tyrphostin AG 538
I-OMe-AG 538 |
IGF-1R; PI3K | PI3K/Akt/mTOR signaling; Tyrosine Kinase/Adaptors |
I-OMe-Tyrphostin AG 538是一种特异性 IGF-1R 抑制剂和 PI5P4Kα的 ATP 竞争性抑制剂(IC50:1 µM)。I-OMe-Tyrphostin AG 538可抑制 IGF-1R 介导的信号传导,并对营养缺乏的 PANC1细胞具有优先细胞毒性。 | |||
T4326 |
AG 555
Tyrphostin B46,Tyrphostin AG 555 |
EGFR; Reverse Transcriptase | Angiogenesis; JAK/STAT signaling; Microbiology/Virology; Tyrosine Kinase/Adaptors |
AG 555 (Tyrphostin B46)是一种选择性EGFR 的有效抑制剂,可阻断Cdk2活化。它是一种抗逆转录病毒药。 | |||
T2693 |
AG1024
Tyrphostin AG 1024,Tyrphostin,AGS 200 |
Apoptosis; IGF-1R | Apoptosis; Tyrosine Kinase/Adaptors |
AG1024 (Tyrphostin) 是一种可逆的,竞争性和选择性的胰岛素样生长因子-1 受体抑制剂,IC50为 7 μM。它抑制胰岛素受体的磷酸化,IC50值为 57 μM。它诱导细胞凋亡并具有抗癌活性。 | |||
T4205 |
AG-494
Tyrphostin AG-494,AG 494,Tyrphostin B48 |
EGFR; CDK | Angiogenesis; Cell Cycle/Checkpoint; JAK/STAT signaling; Tyrosine Kinase/Adaptors |
AG-494 (Tyrphostin B48) 是一种高效、选择性的 EGFR 酪氨酸激酶抑制剂,IC50为0.7 μM。它阻断 Cdk2 的激活并抑制 EGF 依赖的 DNA 合成。它抑制 EGFR、ErbB2、HER1-2 和 PDGF-R 的自磷酸化,IC50为 1.1、39、45 和 6 μM。 | |||
T2600 |
AG490
Zinc02557947,Tyrphostin AG 490,AG 490,AG-490,Tyrphostin B42 |
EGFR; JAK; STAT; Autophagy | Angiogenesis; Autophagy; Chromatin/Epigenetic; JAK/STAT signaling; Stem Cells; Tyrosine Kinase/Adaptors |
AG490 (Tyrphostin B42) 是一种 EGFR 抑制剂 ,IC50为 0.1 μM。它对 EGFR 的选择性比 ErbB2 高 135 倍,还抑制 JAK2。 | |||
T3980 |
Su1498
Tyrphostin SU 1498,AG 1498 |
VEGFR | Angiogenesis; Tyrosine Kinase/Adaptors |
Su1498 (Tyrphostin SU 1498) 是一种选择性的 VEGFR2 抑制剂,能够抑制 Flk-1 (IC50:700 nM)。 | |||
T24912 |
Tyrphostin AG 568
Tyrphostin AG-568,Tyrphostin AG568 |
||
Tyrphostin AG 568 promotes Tyrphostin-induced inhibition of p210bcr-abl tyrosine kinase activity. It also induces K562 to differentiate. | |||
T3545 |
RG13022
RG 13022,Tyrphostin RG13022 |
EGFR | Angiogenesis; JAK/STAT signaling; Tyrosine Kinase/Adaptors |
RG13022 (Tyrphostin RG13022) 是一种酪氨酸激酶抑制剂,抑制EGF 受体自身磷酸化的IC50值为4 μM。 | |||
T24909 |
Tyrphostin 51
Tyrphostin A51,Tyrphostin A-51,Tyrphostin A 51 |
||
Tyrphostin 51 is an effective inhibitor of EGFR kinase. | |||
T5155 |
(E)-AG 99
(E)-Tyrphostin AG 99,(E)-Tyrphostin 46,AG 99,Tyrphostin 46 |
EGFR | Angiogenesis; JAK/STAT signaling; Tyrosine Kinase/Adaptors |
(E)-AG 99 ((E)-Tyrphostin AG 99) 是一种 EGFR 抑制剂。 | |||
T14138 |
AG-825
Tyrphostin AG-825 |
Apoptosis; EGFR | Angiogenesis; Apoptosis; JAK/STAT signaling; Tyrosine Kinase/Adaptors |
AG-825(Tyrphostin C15)是一种具有选择性和竞争性且抑制酪氨酸磷酸化的 ErbB2 抑制剂,其 IC50 值为 0.35 μM。AG-825(Tyrphostin C15)对 HER2 具有抑制作用,在小鼠乳腺癌异种模型中显示出抗癌活性。AG-825(Tyrphostin C15) 是一种潜在的克服锰诱导的神经毒性或阿尔茨海默病发展的活性分子,能促进人中性粒细胞的凋亡,可用于研究乳腺癌。 | |||
T24910 |
Tyrphostin A46
Tyrphostin A-46,Tyrphostin A 46 |
||
Tyrphostin A46 is an antagonist of the epidermal growth factor-urogastrone receptor. | |||
T3554 |
RG14620
Tyrphostin RG14620,RG 14620 |
EGFR; HER | Angiogenesis; JAK/STAT signaling; Tyrosine Kinase/Adaptors |
RG14620 (Tyrphostin RG14620)是一种EGFR 抑制剂,IC50值为3 μM。 | |||
T4092 |
AG126
Tyrphostin AG126,AG 126 |
ERK; COX | Immunology/Inflammation; MAPK; Neuroscience |
AG126 (Tyrphostin AG126) 是一种酪氨酸激酶抑制剂,可阻止丝裂原活化蛋白激酶 p42MAPK(ERK2) 的激活。 | |||
T24911 |
Tyrphostin AG 1112
Tyrphostin AG-1112,Tyrphostin AG1112 |
||
Tyrphostin AG 1112 is a Bcr-Abl kinase blocker. It can activate the terminal differentiation of K562 cells and the purging of Ph+ cells. | |||
T2047 |
AG-1478
AG1478,NSC 693255,Tyrphostin AG-1478 |
EGFR; HCV Protease; Influenza Virus; HER; PDGFR | Angiogenesis; JAK/STAT signaling; Microbiology/Virology; Proteases/Proteasome; Tyrosine Kinase/Adaptors |
AG-1478 (NSC-693255) 是一种选择性 EGFR 酪氨酸激酶抑制剂,IC50为 3 nM。它对 HCV 和脑心肌炎病毒有抗病毒作用。 | |||
T68822 |
Tyrphostin AG17
|
||
Tyrphostin AG17 is a biochemical that promotes adipocyte apoptosis in vivo and is an effective modulator of adipocyte differentiation and WAT hypertrophy in vitro and in vivo. It is thought to possibly be useful as a pharmacological obesity treatment. It is a tyrosine kinase antagonist that has also been found to inhibit tumor cell growth. | |||
T21785 |
AG957
|
Bcr-Abl | Angiogenesis; Cytoskeletal Signaling; Tyrosine Kinase/Adaptors |
Tyrphostin AG957 是一种酪氨酸激酶抑制剂,具有抗BCR/ABL 酪氨酸激酶活性。它能够抑制p210bcr/abl 酶活性 (IC50:2.9 μM)。 | |||
T70392 |
Tyrphostin AG-808
|
||
Tyrphostin AG-808 is a 15-human lipoxygenase inhibitor. | |||
T24908 |
Tyrphostin 47
AG213,AG-213 AG 213 |
||
Tyrphostin 47 inhibits the protein-tyrosine kinase activity of EGF-R. | |||
T1761 |
PD153035 hydrochloride
ZM 252868 HCl,AG 1517,Tyrphostin AG 1517,SU 5271,PD153035 HCl,ZM 252868 |
EGFR | Angiogenesis; JAK/STAT signaling; Tyrosine Kinase/Adaptors |
PD153035 hydrochloride (ZM 252868) 是有效地EGFR 抑制剂,Ki 和IC50值分别为6和25 pM。 | |||
T23660 |
AG1433
Tyrphostin AG-1433,Tyrphostin AG1433,AG-1433,Tyrphostin AG 1433,AG 1433 |
||
AG1433 is a tyrosine kinases inhibitor that acts as a direct and selective inhibitor of photosynthetic PEP carboxylase and an inhibitor of PDGFR-β, Flk-1, and angiogenesis. | |||
T20199 |
AG-1478 hydrochloride
AG1478 HCl,AG-1478 HCl,Tyrphostin,AG1478 Hydrochloride,AG 1478 HCl |
||
AG1478 HCl is an epidermal growth factor receptor protein inhibitor. | |||
T70391 |
AMG151 HCl
|
||
ARRY-403, also known as AMG-151, is an orally available allosteric glucokinase (GK) activator developed for the treatment of type 2 diabetes mellitus (T2DM). ARRY-403 has many favorable physicochemical characteristics and ADME properties (low potential to cause drug–drug interactions (DDIs). ARRY-403 potently activates human glucokinase (GK) in vitro (EC50 = 79 nM at 5 mM glucose), with an S0.5 = 0.93 mM glucose (ARRY-403 at 5 mM) and Vmax = 134% compared to the no activator control. It possesse... | |||
T21853 |
(E)-AG 556
|
EGFR | Angiogenesis; JAK/STAT signaling; Tyrosine Kinase/Adaptors |
(E)-AG 556 是有效的、选择性 EGFR 抑制剂。(E)-AG 556阻断 LPS 诱导的促炎因子 TNF-α 的产生。 | |||
T4605 |
NT157
|
IGF-1R; STAT | JAK/STAT signaling; Stem Cells; Tyrosine Kinase/Adaptors |
NT157 是一种口服生物可利用的间充质-上皮转化 (MET) TKI,主要针对具有 METex14 跳跃突变的特定 NSCLC 患者开发。 | |||
T21783 |
AG-183
|
||
(Z)-Tyrphostin A51 是 Lanoconazole A51 的 Z 构型形式。Tyrphostin A51 是一种有效的蛋白酪氨酸激酶 (PTK)抑制剂,以剂量依赖性方式抑制原代星形胶质细胞培养物中 [3H]牛磺酸的体积敏感释放。Tyrphostin A51 显着降低细胞酪氨酰磷酸化水平。Tyrphostin A51 抑制基础和 EGF 诱导的人骨细胞增殖。 | |||
T60624 |
(E/Z)-AG490
|
||
(E/Z)-AG490 ((E/Z)-Tyrphostin AG490) 是异构体 (E)-AG490 和 (Z)-AG490 的外消旋体。(E)-AG490 是一种可抑制EGFR,Stat-3和JAK2/3的酪氨酸激酶抑制剂。 | |||
T71815 |
TX-1918
|
||
TX-1918 is a cell-permeable tyrphostin derivative that inhibits eukaryotic elongation factor-2 kinase (eEF-2K). TX-1918 disrupts the proliferation of HepG2 and HCT116 tumor cells. | |||
T21784 |
AG-370
|
||
AG 370 是一种吲哚 tyrphostin,是一种有效的PDGF 诱导的有丝分裂抑制剂,IC50值为 20 μM。AG 370 对 EGF 受体的抑制作用较弱。 |